RNXT financials

RenovoRx (RNXT) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

RNXT income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$1.12M$796.00K-$12.51M-$11.17M-0.32
2024$43.00K$43.00K-$10.97M-$8.81M-0.40
2023––-$11.40M-$10.23M-0.99
2022––-$9.95M-$9.89M-1.09
2021––-$5.67M-$6.32M-1.21
2020––-$3.20M-$3.80M-1.72